# VEXUS and NGAL in the Diagnosis and Prognosis of Sepsis-associated Acute Kidney Injury

> **NCT06305403** · — · UNKNOWN · sponsor: **Inonu University** · enrollment: 100 (estimated)

## Conditions studied

- Sepsis
- Acute Kidney Injury

## Interventions

- **DIAGNOSTIC_TEST:** serum creatinin level

## Key facts

- **NCT ID:** NCT06305403
- **Lead sponsor:** Inonu University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-05-01
- **Primary completion:** 2025-03-18
- **Final completion:** 2025-05-18
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06305403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06305403, "VEXUS and NGAL in the Diagnosis and Prognosis of Sepsis-associated Acute Kidney Injury". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06305403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*